Newsletter | 01 February 2003 Access News 8, Focus on Access Three Years On, February 2003 HIV/AIDS RESEARCH AND DEVELOPMENT TROPICAL & NEGLECTED DISEASES VACCINES The Access Campaign three years on is addressed in this issue of AccessNews, as well as the fear of another meningitis epidemic, Roche's failing of HIV patients, fighting against neglected diseases, no agreements at Doha and HIV positive children. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefTopic overviewVideo Letter Letter | 29 June 2023 Diagnostics HIV/AIDS Open Letters: Civil society calls on Abbott and BD to ensure access to HIV CD4 tests Photo credit: Paul Odongo/MSF Press release Press release | 11 May 2023 Diagnostics HIV/AIDS Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production 3 min Technical brief | 11 May 2023 Diagnostics HIV/AIDS Make It Count: Access to Point-of-Care CD4 Testing Under Threat Video Video | 03 May 2023 HIV/AIDS Access challenges for HIV opportunistic infection drug L-AmB Photo credit: Albert Masias/MSF Press release Press release | 03 May 2023 HIV/AIDS MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed 4 min Photograph by Valerie Baeriswyl Press release Press release | 30 March 2023 HIV/AIDS Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug 5 min Technical brief | 02 February 2023 HIV/AIDS Agents of Change: Long-acting Formulations for Prevention and Treatment of HIV Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min Load More
Letter Letter | 29 June 2023 Diagnostics HIV/AIDS Open Letters: Civil society calls on Abbott and BD to ensure access to HIV CD4 tests
Photo credit: Paul Odongo/MSF Press release Press release | 11 May 2023 Diagnostics HIV/AIDS Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production 3 min
Technical brief | 11 May 2023 Diagnostics HIV/AIDS Make It Count: Access to Point-of-Care CD4 Testing Under Threat
Photo credit: Albert Masias/MSF Press release Press release | 03 May 2023 HIV/AIDS MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed 4 min
Photograph by Valerie Baeriswyl Press release Press release | 30 March 2023 HIV/AIDS Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug 5 min
Technical brief | 02 February 2023 HIV/AIDS Agents of Change: Long-acting Formulations for Prevention and Treatment of HIV
Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min
